INTRODUCTION
T he pharmaceutical industry performs microarray studies routinely in search of genes that may help explain biological differences in medical treatments and/or diseases. A high-density oligonucleotide microarray measures the abundance level of thousands of genes in one biological sample simultaneously.
A labeled hybridization sample containing cRNA fragments, derived from a biological sample, is hybridized to short oligonucleotide probes complementary to the RNA which are immobilized on a small glass slide. After the fragments bind to the probes, a laser scanner measures the fluorescence intensity of the probes which represents the abundance level of the genes or the gene expression levels (see Chapter 1 of Parmigiani et al. 1 ).
In addition to biological variation, a microarray study includes both systematic and random measurement error. This is also called the accuracy and the precision of the measurement method, respectively. For the pharmaceutical industry, guidelines have been formulated for the evaluation of analytical measurement systems by the International Harmonisation Committee (ICH) 2 . Accuracy is evaluated in a linearity study, where systematic differences of the method are estimated with respect to several (international) reference standards. The precision of the method is evaluated with specific experimental designs in which the measurement variability is simulated under various conditions that are representative for routine analysis. Three measures of precision are distinguished. Repeatability is the measurement variation that exists in a short period of time, often the measurement variability that occurs in one set of observations or 'run'. Intermediate precision is the measurement variation that exists in a longer period of time, including differences between runs. Differences between runs usually come from different analysts measuring at different days with different apparatus. Reproducibility also includes the measurement variation that exists from different laboratories.
For the microarray technology the accuracy may be determined with 'spiked in' genes in the biological samples at several concentrations (see Affymetrix 3 for publicly available 'spiked in' data sets). The observed gene expression level may then be compared with the known concentration of the spiked in gene. However, such data sets are not always suitable for determining the precision of the method, since it does not represent or simulate the natural measurement variation in routine analysis. Secondly, to evaluate the accuracy and precision of the method for a microarray platform, appropriate data sets should be created with the platform under study.
This article addresses the estimation of the measures of precision, in particular the estimation of repeatability of an Affymetrix microarray platform. The sources of variation that may contribute to the short-term measurement variation are the arrays, possibly from different production lots, the sample preparation steps and the hybridization and washing step. Indeed, in a microarray study, several arrays are hybridized simultaneously in one particular hybridization run. Hence, these variation sources all contribute to repeatability. A specific experimental design that incorporates only these technological sources of variation was performed. Note that Parmigiani et al. 1 classified the sources of variation for microarray technology into array manufacturing, sample preparation, hybridization, scanning and imaging. The sources of variation for the repeatability of the microarray platform fall into the first three categories. Note that accuracy may exist in each of these categories, but possible mainly in the last two categories.
A statistical evaluation of a precision study for an industrial measurement system is often analyzed with a suitable random or mixed effects analysis of variance model. Particular sums of the variance components in such a model are then used to quantify the measures of precision. These measures of precision may then be compared with the specification interval for the quantity of interest or to the total variation, the sum of the measurement and process or product variation.
A mixed effects analysis of variance model on the probe intensity levels is also used for the repeatability study of the microarray platform. The contribution of each of the variation sources was investigated to determine the most critical source with respect to measurement variation. The repeatability is compared with the variation in gene expression levels in the biological sample to judge the microarray platform as a measurement system for gene expression levels. Since the microarray platform is often used to detect differences in gene expression levels between different biological samples, the minimal sample size or number of arrays to detect biologically interesting differences in gene expression is determined. From this statistical inference it is possible to judge the microarray platform for its task of measuring gene expression and selecting differentially expressed genes in future microarray studies.
Analysis of variance models have already been applied to microarray data; see, for instance, Kerr et al. 4 or Chen et al. 5 . However, they applied these models to two-channel microarrays instead of the one-channel microarrays in our experiment. Two-channel microarrays investigate probe intensity differences from two biological samples hybridized simultaneously on one array, while two arrays are required for one-channel microarrays to compare gene expression levels from two biological samples. Although Chen et al. 5 also investigated technological sources of variation, they focused on other sources of variation than the sources of variation incorporated in our experiment.
Other authors use different statistical measures, instead of the usual sums of variance components in a precision study, to determine the influence of technological sources of variation on probe intensity levels or gene expression. For instance, detecting differential expression between samples can be quantified by statistical concepts such as sensitivity and specificity, see James et al. 6 . Such sensitivity and specificity measures are useful for the investigation of the accuracy of a microarray platform in particular. In a precision study that investigates only technological or measurement variation, the sensitivity and specificity analyses reduce to the estimation of false positive rates between settings of the sources of variation only, which is not very informative. Analysis of variance models present more information, give better interpretation to the probe intensity data and give estimates of the measures of precision for microarray platforms, similar to a standard measurement system analysis. Furthermore, analysis of variance models can be very useful in formulating appropriate hypothesis tests and in setting up quality control of microarray platforms.
The following section describes the experimental design and the structure of the array data. Section 3 describes the analysis of variance model, the estimation of the model parameters and the inference from the statistical model. Section 4 presents the results from the statistical analysis and the last section reports the conclusions.
ARRAY DATA AND EXPERIMENTAL DESIGN
For the repeatability study, the HG U133A GeneChip arrays from Affymetrix were used. For each gene or transcript to be represented on the array, one or more probe sets were designed. Each probe set consists of 11 or more probe pairs. Each probe is an oligonucleotide of 25 nucleotides. A probe pair consists of a Perfect Match (PM) probe, which is exactly complementary to the transcript, and a Mismatch (MM) probe, which is a copy of the PM probe where the middle (13th) base is substituted by its complementary base.
The MM probes are intended to correct for non-specific hybridization between the PM probe and unrelated transcripts. The difference in intensity level of the PM probe and the MM probe would result in an estimate of the specific binding or the abundance level. However, Irizarry et al. 7 reported that approximately one third of these differences are negative, which seems clearly uninformative. They also reported, for different reasons, that subtracting or dividing the intensity levels of the PM and MM probes in the original scale is inappropriate. They advise to use the PM probe intensity values alone, see also Chen et al. 8 . Therefore, we will focus mainly on the PM probe intensity levels.
In total, the array contains 22 283 probe sets, which corresponds to 14 500 genes, 68 of which are controls. The control probe sets were not included into the statistical analysis. Furthermore, 494 probe sets do not consist of 11 probe pairs and these probe sets were also excluded from the data. The remaining probe sets are divided into four classes. The identifier of the probe set is a unique number, appended with either ' at', ' s at', ' x at' or ' f at' (with ' at' short for anti-sense target). Since only one probe set is appended with ' f at', it was removed from the data.
The classes indicate the uniqueness of the probe sets for representing a transcript and how well the probes match to the targeted transcript sequence. The probes in class ' at' have 100% sequence identity with their target and are unique. No cross-hybridization is expected. The probes in class 's at' have 100% sequence identity, but all probes also exactly match with other transcripts and are therefore not unique. Probe sets in class 'x at' contain probes that match to their target, but some of these are highly similar or identical to other sequences. Class 'f at' describes probes from an older array type and has the same meaning as 'x at'. Cross-hybridization is expected for probes in classes 's at', 'x at' and 'f at'.
For the statistical analysis, 21 720 probe sets were investigated per array. The number of probe sets per array for class ' at', 's at', 'x at' are 11 348, 7944 and 2428, respectively.
Before a biological sample can be used to hybridize an array, several processing steps are required. For the experiment described in Figure 1 , total RNA from cell line HEK293 (Human Embryonic Kidney) was isolated using Stratagene RNA Isolation Kit. Then cDNA was synthesized and cleaned according to the Affymetrix Technical Manual, Eukaryotic Sample and Array Processing 9 (Section 2). Using this cDNA, cRNA was Figure 1 . Visual representation of the experimental design for technological sources of variation produced with the ENZO Kit and cleaned. Subsequently, cRNA was fragmented and added to the hybridization mix as defined in the Affymetrix Technical Manual. Hybridization mix was applied to HG U133A GeneChip Arrays and allowed to incubate overnight at 45 • C. After washing excess unbound cRNA, arrays were scanned with an Agilent GeneArray scanner. The technological sources of variation considered for the repeatability study were:
• GeneChip array production lot;
• GeneChip arrays;
• reverse transcription step (cDNA sample);
• in vitro transcription step resulting in hybridization and washing mix (cRNA sample);
• hybridization step.
Indeed, each of these sources may be present in one particular hybridization run, in which multiple arrays are processed. Note that a distinction between the reverse and in vitro transcription step is not necessary for the estimation of the repeatability. It was investigated separately to learn which step is more critical in processing the biological material. The experiment contains 16 arrays and the experimental design is visualized in Figure 1 . The total amount of PM probe intensity levels in the statistical analysis of this experiment, after excluding parts of the array data as described above, is equal to 3 822 720. Note that the MM probe is directly located under the PM probe on the array but the probe pairs from one probe set are located at different positions on the array.
STATISTICAL ANALYSIS
This section consists of three parts. The first part describes the mixed effects analysis of variance model. The second part presents the estimates of the model parameters and describes a technique to diminish the influence of the technological sources of variation in microarray studies. The last part describes the statistical inference from the model parameters.
Statistical model
The factors present in the experimental design that will be incorporated in the mixed effects analysis of variance model are:
• A, gene probe set;
• B, cDNA sample;
• C, array production lot; • D:A, probe within gene probe set;
• E:B, cRNA sample within cDNA sample; • F:BCE, array within the interaction of array production lot and cRNA sample within cDNA sample.
Then the mixed effects analysis of variance model for these factors with all possible interaction terms is described mathematically by
with y ijklmn the response variable for probe l within probe set i in cRNA sample m from cDNA sample j measured on array n from array production lot k and with i = 1, 2, . . . ,
Note that the analysis of variance model may be adjusted to other data sets in case additional (or less) sources of variation are considered for the determination of precision measures. The effects of probe sets and probes within probe sets are considered fixed, since each cRNA sample comes from one and the same total RNA sample. For the fixed effects of probe sets and probes within probe sets the following restrictions are required for identifiability of the parameters of model (1):
Furthermore, note that the parameter µ + α i may be considered as the mean expression level of probe set i based on the PM probe intensity levels. There exists no generally accepted method for calculating the probe set expression level and different calculation procedures are used which incorporate all kinds of correction methods, see Irizarry et al. 7, 10 . Based on model (1), our definition of the probe set expression level seems logical, has a clear interpretation and statistical features are mathematically easily determined. All possible interaction terms are included in model (1), since no initial knowledge on the relevance of these terms was present. Furthermore, the experiment was set-up to estimate the influence of the sources of variation and not for testing each individual variance component against zero. We believe that testing is only meaningful if an appropriate sample size has been calculated initially to the experiment that is based on a relevant biological criterium for the variance components. On the other hand, terms that are significant with this experiment do show at least statistical relevance.
The random main effects and the random interaction terms ln(ijkm) and ε ijklmn are all assumed to be mutually independently normally distributed with mean zero and variances
To satisfy the statistical assumptions of model (1) as much as possible, the response variable y ijklmn will be equal to a power or Box-Cox transformation of the PM probe intensity levels. The power transformation will be determined from the PM probe data only. Other variance stabilizing transformations of two-channel microarray data have been discussed by Huber et al. 11 . Furthermore, the assumptions for model (1) with the Box-Cox transformation will be investigated through a residual analysis, see, for instance, Draper and Smith 12 .
The residual analysis will investigate homogeneity of variances, normality of the residuals and outlier intensity levels.
Estimation and normalization
The variance components in model (1) will be estimated by appropriate linear combinations of the mean squares from the analysis of variance table. These linear combinations are such that the estimates are unbiased estimates of the variance components. The estimates are presented in Appendix A and will be indicated with a 'hat'. 
Note that the variance components σ 2 DF:BCDE and σ 2 cannot be estimated separately but the sum of these two variance components σ 2 R = σ 2 DF:BCDE + σ 2 can be estimated. In case any estimate of the variance component is negative the estimate will be set equal to zero.
Microarray data are often 'normalized' to reduce the influence of technological sources of variation, see, for instance, Chen et al. 13 or Bolstad et al. 14 . In general, we may distinguish between three types of normalization procedures: linear normalization, nonlinear normalization and non-parametric normalization. Linear normalization adjusts each intensity value with the same amount such that the array averages are all equal. Nonlinear normalization does the same but lets the adjusted amount depend on the intensity level. Nonparametric normalization makes the 'distribution' of probe sets on an array equal to all arrays by setting the quantiles of the probe set expression levels per array equal. Furthermore, each normalization procedure can be applied either globally or locally. Global normalization uses all probe sets or probes while local normalization uses only a portion of the probe sets or probes, such as controls, see Chen et al. 8 .
For the analysis of variance model (1) we investigate the impact of linear normalization of all PM probe intensity levels on the contribution of the technological sources of variation. This normalization method is an array-wise mean normalization. Hence, the normalized probe intensity levels, say z ijklmn , are formulated as
withȳ .j k.mn the nth array average from production lot k with cRNA sample m from cDNA sample j and with y the overall average of the response variable of all PM probes. This normalization sets the sums of squares SS B , SS C , SS BC , SS E:B , SS CE:B and SS F :BCE for cDNA sample, array production lot, the interaction between cDNA sample and array production lot, cRNA sample nested within cDNA sample, the interaction between array production lot and cRNA sample nested within cDNA sample and array nested within the combination of cRNA sample, cDNA sample and array production lot equal to zero and leaves all the other sums of squares unchanged. It is possible that nonlinear and non-parametric normalization may correct for interaction terms between probe sets and the technological sources of variation and that they may correct for interaction terms between probes within probe sets and the technological sources of variation. However, these two normalization procedures are difficult or even impossible to evaluate mathematically. Furthermore, the nonlinear and non-parametric normalization procedures may also affect the biological pattern in microarray studies with different biological samples. Therefore, we restricted this work to linear normalization.
Statistical inference
Interesting and important statistics may be calculated from the variance components in model (1) . Particular sums of variance components are of interest to investigate the contribution of each technological source of variation. Table I presents these sums of variances and shows the connection to the technological source of variation.
Note that the interaction terms of the technological sources of variation and the probe set and the technological sources of variation and the probes within probe sets are contributing to the technological sources of variation since the probe sets and probes within probe sets are considered fixed. The total contribution of all the technological sources of variation is now set equal to
The standard deviation τ T can be considered as the repeatability of the microarray platform for the determination of the probe intensity levels. It is the measurement or technological variation in the probe intensity levels within one particular hybridization run on a randomly selected array from a randomly selected array production lot.
Estimates of the sums of variance components or contributions in Table I and in (4) are obtained by plugging in the estimates of the appropriate variance components. Confidence intervals on the contributions may be calculated with the procedure described by Burdick and Graybill 15 (Section 3.3); see also Appendix B. These contributions and the corresponding 95% confidence intervals will be estimated for the non-normalized and normalized data.
From the variance components several correlation coefficients are important for the evaluation of the microarray platform. The correlation coefficient between probes from different probe sets on the same array is equal to
and for probes from the same probe set on the same array it is equal to
These correlation coefficients give insight in the amount of information present in the data. If the correlation coefficient ρ B is close to zero, then the microarray platform is suitable for measuring thousands of genes on one array simultaneously, since the probes from different probe sets behave almost uncorrelated. If the correlation coefficient ρ B is close to one, then each array measures essentially only one probe. The correlation coefficient ρ W indicates how much information is present in the probes from one probe set.
The estimates for the correlation coefficients are determined by plugging in the estimates for the appropriate variance components. These estimates for the correlations will be calculated for the non-normalized and normalized data. Note that correlation between probes on one array was already observed and published, see Parmigiani et al. 1 .
To determine differentially expressed probe sets from different biological samples using only the PM probe intensity levels, one may calculate the average probe intensity level per array and probe set, i.e.ȳ ijk.mn . As mentioned before, this average may be considered as the probe set expression level of probe set i on array n from array production lot k with cRNA sample m from cDNA sample j and it is an estimate for the mean probe set expression level µ + α i . The variance of the average expression levelȳ ij k.mn , based on model (1), is critical in detecting differences between probe set expression levels from different biological samples. This variance σ 2 G is defined in terms of the variance components as
The standard deviation σ G can be considered as the repeatability of the microarray platform for the determination of the probe set expression level. It is the measurement or technological variation of the microarray platform for the determination of the probe set expression levels determined in one hybridization run measured on a randomly selected array from a randomly selected array production lot. The estimate for this variance is obtained by plugging in the estimates of the appropriate variance components. Note that this variance may also be calculated after the linear normalization has been applied.
A statistic that is often used to evaluate the repeatability of a measurement system in industry is the correlation coefficient ρ M , see Burdick et al. 16 . This correlation coefficient is used in particular in case no specification limits are available for the quantity of interest. Indeed, for the probe set expression levels there exist no such limits and, hence, for the microarray platform, this correlation coefficient is defined as
with σ 2 A the variance of the (fixed) mean expression levels (µ + α i ). Note that the correlation coefficient in (8) indicates a percentage contribution of the repeatability for the determination of the probe set expression level with respect to the total variation in measuring one biological sample.
In general, a measurement system is considered 'good' if this ratio is below 0.1, the measurement system is 'unacceptable' if the ratio is above 0.3 and the measurement system is considered 'marginal' otherwise, see Burdick et al. 16 . Note that these criteria are commonly accepted for technical and industrial measurement systems, but we are not familiar with these criteria for systems measuring biological material. On the other hand, the ratio in (8) will inform us about the appropriateness for measuring probe set expression levels of the microarray platform in the range of observed probe set expression levels. In particular, it will tell us if the system can make a distinction between probe sets that are expressed or present in the biological material or not. The correlation coefficient ρ M will be estimated both for the non-normalized and normalized data.
Since ρ M indicates the appropriateness of measuring differences between probe sets within the range of probe set expression levels, it does not guarantee that biologically interesting differences in probe sets between biological samples can be detected. To judge the microarray platform for gene selection the minimum number of arrays n will be calculated based on a biological relevant difference in mean probe set expression levels and the variance in (7). The well-known approximate formula for sample size calculation n is equal to
with α the significance level and 1 − β the power. The significance level will be set equal to 0.05 and the power will be set equal to 0.9. The minimal sample size will be calculated for the non-normalized and normalized PM probe intensity levels. Note that the sample size is based on repeatability of the probe set expression level only. Biological variation should be added to the variance in (7) if probe sets are compared between, for instance, different treatments and biological samples within one treatment are hybridized to different arrays and not pooled before hybridization. If the minimal sample size in (9) is small, then the repeatability has only a marginal or small effect on the sample size calculation in microarray studies and the biological variation determines the number of arrays. Hence, the microarray platform is then suitable for investigating differences in genes between biological samples.
All of these statistical measures in (4)- (9) contribute to the determination of the performance of the microarray platform as a measurement system.
STATISTICAL RESULTS
This section is split into two parts. The first section describes the results of the statistical model and the statistical inference from the model. The second section discusses the goodness-of-fit of the statistical model.
Statistical model and inference
For the Box-Cox transformation 17 , the power parameter λ was ranged from −0.25 to 0.25 in steps of 0.05 and the sums of squares for the residual term for model (1) were calculated for each value of λ. The Box-Cox transformation indicated that a logarithmic transformation of the PM probe intensity levels is appropriate since the minimum sum of squares is located near the power parameter λ = 0. Note that a logarithmic transformation implies that the ratio of geometric averages can be used to select probe sets between different biological samples. The logarithmic transformations are often applied to gene expression data and to probe intensity data, see Parmigiani et al. 1 and Irizarry et al. 10 , respectively. Furthermore, the linear normalization procedure in (3) is just a scaling procedure of the PM probe intensity levels that makes the array averages equal. The analysis of variance table for the logarithmically transformed PM probe intensity levels is presented in Table II . Many of the performed tests, indicated with an asterisk, are not exact F -tests. The hypothesis tests are performed with the approximation method of Satterthwaite (see Searle 18 , p. 413). Note that the degrees of freedom for some terms are very large while for other terms it is only one. This is, of course, caused by the large amount of genes on one array. The large degrees of freedom will make F -values just above the value one highly significant.
Based on the mean squares from the analysis of variance table, the individual variance components for the logarithmically transformed PM probe intensity values may be estimated. See the linear combinations of means squares in Appendix A.
The sums of variance components in Table I may then be estimated from the estimates of individual variance components. These sums of variances, the percentage contribution with respect to the repeatability for the probe intensity levels in (4), the standard deviations and the corresponding 95% confidence intervals are presented in Table III . For the normalized data these results are presented in Table IV .
The variances can be transformed back to a relative standard deviation for the original PM probe intensity levels via 100 exp(σ 2 X ) − 1, with X indicating one of the factors from Tables III and IV. The relative standard deviations for the repeatability for the probe intensity levels are then estimated at 57.4 and 23.5% for the nonnormalized and normalized data, respectively. Clearly, the normalization procedure reduces the influence of the technological or measurement variation dramatically, which was already obvious from Tables III and IV. This large reduction in the contribution of the technological source of variation by the normalization procedure implies that the sources of variation contribute mainly in an additive way and contribute less in an interaction with probe sets or with probes within probe sets. On the other hand, from the analysis of variance table it follows that the in vitro transcription step interacts with probe sets and with probes within probe sets. Although more interaction terms are statistically significant, the significant interaction terms AE:B and DE:AB are the only terms with a relative large F -value (at least more than three). For the non-normalized and normalized data, the 'cRNA sample', 'cDNA sample' and 'hybridization step' contribute most to the logarithmically transformed PM probe intensity levels. It is clear that the in vitro transcription step is most dominating before and after normalization. Furthermore, the array manufacturing step seems less critical than the processing steps for preparing the hybridization mix and the hybridization and washing step, if the results of the experiment may be generalized to other microarray studies.
The correlation coefficient ρ B for probe intensity values on one array for probes from different probe sets is estimated with 0.81. For probes within the same probe set on one array, ρ W is estimated at 0.90. This implies strong correlation between the PM probes on one array and only limited information is present on one array. However, for the normalized PM probe intensity values, these correlation coefficients reduce to 0.00 and 0.45, respectively. Clearly, linear normalization increases the amount of information present on one array. The zero correlation coefficient implies that the microarray platform is suitable for measuring thousands of probe sets simultaneously since the probes from different probe sets on one array behave almost independent under the assumptions of model (1) . This also implies that probe set expression levels on one array is independent under the assumptions of model (1) after linear normalization is applied. Furthermore, each probe from one probe set on one array does contribute to the interrogation of the corresponding probe set since the correlation coefficient ρ W is considered marginal after linear normalization is applied.
The variance σ 2 G of the average probe set expression level is estimated at 0.2578 and 0.0268 for the nonnormalized and normalized PM probe intensity levels. The relative standard deviations for the probe set expression levels in the original scale are then estimated at 54.2 and 16.5% for the non-normalized and normalized data, respectively. The variance between the mean probe set expression levels σ 2 A is estimated at 0.5507 for the non-normalized and normalized data. Note that the linear normalization procedure does not affect variation in probe set expression levels, one of the advantages of linear normalization. The correlation coefficient ρ M is now estimated at 0.319 and 0.046 for the non-normalized and normalized data, respectively. From these estimates the platform seems certainly suitable for measuring probe set expression levels in case the normalization procedure is applied. Without the normalization procedure the estimate is just above the limit for a marginal measurement system. Considering the fact that the measurement system measures biological material, the microarray platform is not considered as an unacceptable system if normalization is not applied. Furthermore, with and without normalization, the microarray platform is particular suitable for detecting probe sets that are present in biological material. The estimation of the minimal sample size for probe set selection, based on the repeatability for the probe set expression levels only, is presented in Table V for the non-normalized and normalized data. The fold-change in Table V is the minimal detectable ratio of two expression levels in the original intensity scale for one probe set from two different biological samples. A probe set is not differentially expressed if the fold-change is equal to one.
From Table V it is clear that normalization is imperative in the case when probe set selection is the goal of a microarray study. Without normalization it is difficult to detect differentially expressed probe sets. This is certainly true if biological variation should be added to the measurement variation. With normalization, fold changes of more than 1.5 are easily detected in case only measurement or technological variation is present in microarray studies. Indeed, in some microarray studies the biological samples from one treatment are (necessarily) pooled to one biological sample per treatment and only technological replicates are incorporated. Furthermore, it is expected that microarray studies with cell lines as the biological samples, do not add much variation to the measurement or technological variation. If biological variation is confounded with technological variation and normalization is used, then the biological variation will determine the sample size.
If (global) normalization is possible, then the current platform seems suitable for measuring thousands of probe sets simultaneously, for measuring probe sets within the observed range of probe set expression levels and for probe set selection, assuming that the estimation of the repeatability in the experiment is representative for microarray studies in the future. Note that global normalization (normalizing on all PM probe intensity levels) is possible only if few probe sets (relative to the total amount of probe sets) are truly differentially expressed or if the differentially expressed probe sets cancel each other out between different biological samples, see Chen et al. 8 . A difference in the average signal per treatment is then hardly affected by treatment and the biological patterns are not distorted by global normalization.
Goodness of fit of statistical model
To evaluate the statistical model (1) we investigate the standardized residuals against the predicted values graphically, see Figure 2 of the standardized residuals for array one. The standardized residuals are the residuals of model (1) divided by the square root of the mean square error of model (1), i.e. divided byσ R . According to Draper and Smith 12 this standardization is suitable for most graphical investigations of the residuals. Note that the other arrays show a similar graph. Figure 2 clearly shows a 'submarine-shaped' or 'cigar-shaped' pattern. This pattern differs from the 'fish-tail' pattern often found in microarray studies for probe set expression in the logarithmic scale, see Parmigiani et al. 1 . Note that many calculation procedures are described for the probe set expression level, including background Figure 2 . Plot of the standardized residuals against the predicted logarithmically transformed PM probe intensity levels for array 1 substraction and averages of differences of PM and MM probe intensity levels, see Irizarry et al. 10 . The 'fishtail' pattern shows much more variation at low intensity levels compared with the variation at high intensity levels. The 'submarine-shaped' pattern shows much less inhomogeneity of variances than a 'fish-tail' pattern, although some inhomogeneity of variance depending on the intensity level might still be present.
To investigate the homogeneity of variances further, the technological sources of variation are determined for the different annotation classes separately. In case large differences are observed, then model (1) should incorporate variance components per class. Table VI shows the estimates for the sums of variance components in Table I for the class ' at', 's at' and 'x at'. Not much difference is seen between the three annotation classes, although the standard deviation for the contribution of the total technological variation is somewhat larger in the class ' at'. This means that the technological sources of variation behave similar for the three classes. The classes 's at' and 'x at' contain probes that are not unique for their targets, but this has no or hardly any influence on the total technological variation.
From Figure 2 it may be observed that some PM probe intensity levels deviate from the predicted value. These values may be considered as statistical outliers. Table VII presents the number of PM probes per array that deviate more than three, four, five and six times the residual standard deviation away from the predicted value. The expected number of PM probes, based on the assumption of normality, is also presented in the table.
Note that the number of outliers for arrays 2, 4, 6, 8, 10, 12, 14 and 16 are equal to the number of outliers on arrays 1, 3, 5, 7, 9, 11, 13 and 15, respectively. The difference in the number of outliers per array changes from array to array. This means that some arrays do behave somewhat better than other arrays. Spots or scratches on the array might be a reason for outliers, although the visual inspection of the 16 arrays did not show serious problems.
It should also be noted that the number of outliers deviate from the expected number of PM probe intensity levels. However, the portion of PM probe intensity levels deviating from the predicted values is small considering that 238 920 PM probes per array were investigated. If no particular cause for the outliers is present, then one must conclude that the distribution of the residuals is non-normal. A probability plot of the residuals will clearly show that, but a histogram of the standardized residuals of array 1 shows that the distribution is not dramatically non-normal, considering the amount of PM probes, see Figure 3 . Note that normality will be less of an issue for the probe set expression level due to the central limit theory.
Note that several procedures have been proposed for dealing with outlier PM probe intensity levels in relation to the calculation of probe set expression levels, see, for instance, Irizarry et al. 10 and Li and Wong 19 . For instance, weighted averages of PM probe intensity levels per probe set can be calculated, giving the outlier intensity levels a lower weight. There were no probe sets with outlier probes common to all arrays, although there were probe sets that had outlier probes on more arrays (from the odd numbered or even numbered arrays). This means that the observed outliers do not occur completely random from array to array. Therefore, we are not completely convinced that the somewhat thicker tail with respect to a normal distribution is not inherent to microarray studies and that the outlier probes should receive less weight in the calculation of the probe set expression. Giving each PM probe intensity level the same weight in the calculation of probe set expression will possibly induce a somewhat lesser performance of the microarray platform as a measurement system.
The residual analysis shows us that the analysis of variance model (1) does not fit perfectly to the PM probe intensity levels. Some inhomogeneity of variance seems present and normality also seems somewhat violated. However, due to the huge amount of data the residuals do not deviate too much from the statistical assumptions to be concerned about the statistical inference for the microarray platform. Based on this experiment it seems quite reasonable to use analysis of variance models on the raw PM probe intensity levels without any correction measures. The analysis of variance model can also be used to normalize the data, which was also proposed by Kerr et al. 4 . Applying model (1) to the logarithmically transformed MM probe intensity levels gives an estimate of the standard deviation of total technological variation in (6) equal toτ T = 0.6121 with 95% confidence interval [0.436, 13.70]. This seems somewhat larger than the total variation in the PM probe intensity levels. The percentage contribution of each source of variation to the total technological variation is similar to the percentages for the PM probe intensity values. Furthermore, approximately a quarter of the MM probe intensity levels are larger than the PM probe intensity levels for each array in the experiment. Investigating the correlation between the residuals of the PM probe intensity levels of model (1) with the residuals of the MM probe intensity levels of model (1) gives an estimate for the correlation coefficient of 0.55. This means that a positive correlation between the PM and MM probes, given the array, is observed.
Clearly, a calculation of probe set expression levels based on the ratio of the PM and MM probe intensity level or on the difference of PM and MM probe intensity levels will increase the repeatability for the probe set expression levels compared with the repeatability for probe set expression levels based on the average of the PM probes alone. This means that the performance of the microarray platform as a measurement system also reduces for such probe set expression levels, with respect to the average probe set expression level of the PM probe intensity levels alone. Therefore, if probe sets are indeed represented adequately by the PM probes, we also recommend the use of PM probes in the calculation of probe set expression only and follow, in that respect, Irizarry et al. 8 and Chen et al. 8 .
CONCLUSIONS AND DISCUSSIONS
From the statistical analysis of a repeatability study for a Affymetrix high-density oligonucleotide microarray platform, including five technological sources of variation, representing array manufacturing, biological sample processing and hybridization and washing, it was found that the in vitro transcription step in the sample preparation was most critical for the repeatability of the probe intensity levels. This source of variation contributes more than 50% of the total measurement variation. The hybridization step and the reverse transcription step contribute more than the array-to-array variation and the array-lot-to-array-lot variation. The array manufacturing sources of variation were not critical at all.
The global linear normalization procedure reduced the total measurement variation with more than 80% with respect to non-normalized data. However, the order of importance of the variation sources did not change much by the linear normalization procedure. The high correlation between PM probes from different probe sets on one array without normalization was reduced to zero in case linear normalization was applied. This implies that the microarray platform is capable of measuring thousands of genes simultaneously on one array, because probes from different probe sets may be considered uncorrelated. This implies that the correlation between probe set expression levels on one array is also reduced to zero with linear normalization.
It was observed that the microarray platform is suitable for measuring probe set expression within the observed range of probe set expression levels. In particular, a distinction between probe sets that are present or not present in the biological material is easily achieved. If linear normalization is applied the microarray platform is considered a good measurement system with respect to the commonly accepted criteria from industry for measurement systems.
The microarray platform can also be used for probe set selection if normalization is applied. The required number of arrays in a microarray study for detecting differentially expressed probe sets between biological samples is marginally increased by the technological sources of variation. Without normalization it is more difficult to detect differences in probe set expression levels from different biological samples with the microarray platform or substantially more arrays are required in an experiment.
The statistical assumptions for the analysis of variance model applied to the probe intensity levels are somewhat violated. The residual analysis showed some inhomogeneity of variance and showed a deviation of normality. Considering the amount of data in the experiment, the analysis of variance model seems suitable for describing PM probe intensity levels. In particular, the model is useful for describing the probe set expression level as an average of PM probe intensity levels, since normality would be of no issue due to the central limit theory.
Even for other more complicated calculations of probe set expression levels as a function of PM probe intensity levels the model is still useful. The approximate underlying normal distribution of the PM probe intensity levels can be used to determine the (approximate) distribution of the more complicated probe set expression level. This may help determine probe set selection in future microarray studies in case other probe sets expression levels are biologically more informative. Bivariate analysis of variance models may possibly be used to describe the PM and MM probe intensity levels simultaneously, which presents the possibility to also incorporate the MM probe intensity levels in the calculation of probe set expression levels and establish the distribution of the probe set expression level. However, we expect that the performance of the microarray platform as a measurement system will decrease since the MM probe intensity level will add to measurement or technological variation additional to variation in the PM probe intensity levels. 
APPENDIX B
Each estimatorτ 2 X for a contribution τ 2 X in Table I , with X indicating the factor, can be written into a linear combination of mean squares in the following way: X is not negative since each estimate of a variance component is set equal to zero in case the estimate of the linear combination of mean squares is negative. Thus, there are P positive terms and Q − P negative terms appearing inτ 2 X . The lower and upper bound for an 1 − 2α confidence interval on τ 2 X is, respectively,
with V L and V U defined by the pth percentile of the F distribution with r and s degrees of freedom of the numerator and denominator, respectively, and with n i the degrees of freedom for the mean square θ i . If P = 1 then G * ij is defined to be zero and in case Q = P + 1 then H * ij is set equal to zero. In the case Q = P , the procedure for calculating confidence intervals is called the modified large-sample method, see Burdick and Graybill 15 . The confidence interval is calculated as above with V L and V U calculated as the first sum in the definition of V L and V U listed above.
